Yep, this has been an absolute disaster.
Should have sold at $0.70. I thought the traction they were getting was solid.
It has imploded. Will take a while to get back to those heights.
It's almost similar to a drug developer that failed their trial. We had a softening sales (flat worldwide sales, but slightly increasing US sales) but coupled with our cash position and large holders selling down has caused this to crash IMO.
Hopefully the plant in Costa Rica lowers our costs. Board did say that they have sufficient cash for 2018. I would think this will recover somewhat after the quarterly is released.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 29583410 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 59394450 | 39 |
View Market Depth
| Last trade - 16.13pm 20/06/2025 (20 minute delay) ? |
| AXP (ASX) Chart |
Day chart unavailable